Diabetic Gastroparesis Market

The term diabetic gastroparesis (DGp) has been used to describe a serious complication of diabetes resulting in delayed gastric emptying with associated upper gastrointestinal (GI) symptoms in the absence of any mechanical obstruction. The usual treatments for DGp include nutritional assessment and dietary modifications, glycemic control, prokinetic agents, and antiemetic agents.

Diabetic Gastroparesis Market Key Facts
Among the 7MM, the US is expected to account for the 62% USD of the overall market size of Diabetic Gastroparesis in 2030.
Among the EU-5 countries, Germany accounts for the highest market size for Diabetic Gastroparesis followed by the United Kingdom, Spain, Italy.
Among the Diabetic Gastroparesis patients, females account for a higher number of Diabetic Gastroparesis cases in comparison to males.
The highest prevalent population of Diabetic Gastroparesis among 7MM is in the United States.

For more details visit:
https://www.delveinsight.com/report-store/diabetic-gastroparesis-market-size